106 related articles for article (PubMed ID: 2282995)
1. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa.
Kald B; Olaison G; Sjödahl R; Tagesson C
Digestion; 1990; 46(4):199-204. PubMed ID: 2282995
[TBL] [Abstract][Full Text] [Related]
2. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.
Kald B; Smedh K; Olaison G; Sjödahl R; Tagesson C
Digestion; 1996; 57(6):472-7. PubMed ID: 8913710
[TBL] [Abstract][Full Text] [Related]
4. [Presence paf-acether mediator of inflammation in stools of patients with inflammatory enterocolitis].
Denizot Y; Chaussade S; Colombel JF; Benveniste J; Couturier D
C R Acad Sci III; 1991; 312(7):329-33. PubMed ID: 1908742
[TBL] [Abstract][Full Text] [Related]
5. PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.
Denizot Y; Chaussade S; Nathan N; Colombel JF; Bossant MJ; Cherouki N; Benveniste J; Couturier D
Dig Dis Sci; 1992 Mar; 37(3):432-7. PubMed ID: 1735366
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF-acether) formation in neonatal intestinal mucosa and in cultured intestinal epithelial cells.
Kald B; Gustafson C; Franzén L; Weström B; Sjödahl R; Tagesson C
Eur Surg Res; 1992; 24(6):325-32. PubMed ID: 1292936
[TBL] [Abstract][Full Text] [Related]
7. Ileal and colonic fatty acid profiles in patients with active Crohn's disease.
Bühner S; Nagel E; Körber J; Vogelsang H; Linn T; Pichlmayr R
Gut; 1994 Oct; 35(10):1424-8. PubMed ID: 7959199
[TBL] [Abstract][Full Text] [Related]
8. Ileal and colonic mucosal bile acids in Crohn's disease and right colonic carcinoma.
Kurtz WJ; Leuschner U; Strohm WD; Classen M
Tokai J Exp Clin Med; 1985 Apr; 10(1):47-50. PubMed ID: 4095712
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
Hocke M; Richter L; Bosseckert H; Eitner K
Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
[TBL] [Abstract][Full Text] [Related]
10. Lipocortin-present perforating and lipocortin-absent nonperforating Crohn's disease.
Sakanoue Y; Horai T; Okamoto T; Hatada T; Shoji Y; Fujita S; Kusunoki M; Utsunomiya J
Am J Surg; 1992 Oct; 164(4):341-4. PubMed ID: 1415941
[TBL] [Abstract][Full Text] [Related]
11. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
[TBL] [Abstract][Full Text] [Related]
12. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
13. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Rachmilewitz D; Eliakim R; Simon P; Ligumsky M; Karmeli F
Agents Actions; 1992; Spec No():C32-6. PubMed ID: 1359744
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
16. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.
Mulder TP; Verspaget HW; Janssens AR; de Bruin PA; Peña AS; Lamers CB
Gut; 1991 Oct; 32(10):1146-50. PubMed ID: 1955169
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
Almer S; Kald B; Franzén L; Ström M; Tagesson C
Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet-activating factor (PAF-acether) in cultured intestinal epithelial cells (INT 407).
Gustafson C; Kald B; Sjödahl R; Tagesson C
Scand J Gastroenterol; 1991 Oct; 26(10):1000-6. PubMed ID: 1947765
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in mucin gene expression in Crohn's disease.
Buisine MP; Desreumaux P; Debailleul V; Gambiez L; Geboes K; Ectors N; Delescaut MP; Degand P; Aubert JP; Colombel JF; Porchet N
Inflamm Bowel Dis; 1999 Feb; 5(1):24-32. PubMed ID: 10028446
[TBL] [Abstract][Full Text] [Related]
20. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
